Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

Published:2020-04-01 Issue:4 Volume:6 Page:512
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Kichenadasse Ganessan¹²,Miners John O.¹,Mangoni Arduino A.¹,Rowland Andrew¹,Hopkins Ashley M.¹,Sorich Michael J.¹

Affiliation:

1. College of Medicine and Public Health, Department of Clinical Pharmacology, Flinders University, Bedford Park, South Australia, Australia

2. Flinders Centre for Innovation in Cancer, Department of Medical Oncology, Flinders Medical Centre, Flinders University, Bedford Park, South Australia, Australia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2757521/jamaoncology_kichenadasse_2019_oi_190098.pdf

Reference31 articles.

1. Immune checkpoint inhibitors in the management of lung cancer.;Zimmermann;Am Soc Clin Oncol Educ Book,2018

2. Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers.;Hopkins;Br J Cancer,2017

3. The obesity paradox in cancer: a review.;Lennon;Curr Oncol Rep,2016

4. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer.;Morel;Lung Cancer,2018

5. Abdominal obesity and lung cancer risk: systematic review and meta-analysis of prospective studies.;Hidayat;Nutrients,2016

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer;Translational Research;2024-10

2. Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers;BMC Medicine;2024-09-11

3. Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer;Journal of Clinical Investigation;2024-09-03

4. Impacts of sarcopenia with or without obesity on patients with gastric cancer;Holistic Integrative Oncology;2024-08-30

5. Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy;Frontiers in Immunology;2024-08-26